These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 26370119

  • 21. Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.
    Vu TL, Nguyen TT, Doan VTH, Vo LTT.
    Asian Pac J Cancer Prev; 2018 Jul 27; 19(7):1887-1893. PubMed ID: 30049201
    [Abstract] [Full Text] [Related]

  • 22. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues.
    Kupčinskaitė-Noreikienė R, Skiecevičienė J, Jonaitis L, Ugenskienė R, Kupčinskas J, Markelis R, Baltrėnas V, Sakavičius L, Semakina I, Grižas S, Juozaitytė E.
    Medicina (Kaunas); 2013 Jul 27; 49(8):361-6. PubMed ID: 24509146
    [Abstract] [Full Text] [Related]

  • 23. Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis.
    An N, Shi Y, Ye P, Pan Z, Long X.
    Cell Physiol Biochem; 2017 Jul 27; 42(6):2430-2440. PubMed ID: 28848211
    [Abstract] [Full Text] [Related]

  • 24. Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.
    Xu J, Shetty PB, Feng W, Chenault C, Bast RC, Issa JP, Hilsenbeck SG, Yu Y.
    BMC Cancer; 2012 Jun 13; 12():243. PubMed ID: 22695491
    [Abstract] [Full Text] [Related]

  • 25. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT, Dobrovic A, Yan M, Karim RZ, Lee CS, Lakhani SR, Fox SB.
    Breast Cancer Res Treat; 2010 Nov 13; 124(2):555-65. PubMed ID: 20563638
    [Abstract] [Full Text] [Related]

  • 26. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova A, Kajo K, Lasabova Z, Plank L, Danko J.
    Oncol Rep; 2013 Dec 13; 30(6):2878-86. PubMed ID: 24068440
    [Abstract] [Full Text] [Related]

  • 27. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
    Hafez MM, Al-Shabanah OA, Al-Rejaie SS, Al-Harbi NO, Hassan ZK, Alsheikh A, Al Theyab AI, Aldelemy ML, Sayed-Ahmed MM.
    Asian Pac J Cancer Prev; 2015 Dec 13; 16(2):541-9. PubMed ID: 25684485
    [Abstract] [Full Text] [Related]

  • 28. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
    Ahmad F, Surve P, Natarajan S, Patil A, Pol S, Patole K, Das BR.
    Cancer Genet; 2020 Feb 13; 241():42-50. PubMed ID: 31653608
    [Abstract] [Full Text] [Related]

  • 29. DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study.
    Vineis P, Chuang SC, Vaissière T, Cuenin C, Ricceri F, Genair-EPIC Collaborators, Johansson M, Ueland P, Brennan P, Herceg Z.
    Epigenetics; 2011 Feb 13; 6(2):195-201. PubMed ID: 20978370
    [Abstract] [Full Text] [Related]

  • 30. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug 13; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 31. Methylation analysis of APC, AXIN2, DACT1, RASSF1A and MGMT gene promoters in non-small cell lung cancer.
    Paschidis K, Zougros A, Chatziandreou I, Tsikalakis S, Korkolopoulou P, Kavantzas N, Saetta AA.
    Pathol Res Pract; 2022 Jun 13; 234():153899. PubMed ID: 35489124
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 34. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
    Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, Liang JD, Chiou LL, Huang GT, Lee HS.
    Int J Cancer; 2007 Sep 15; 121(6):1257-64. PubMed ID: 17534893
    [Abstract] [Full Text] [Related]

  • 35. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.
    Switzeny OJ, Christmann M, Renovanz M, Giese A, Sommer C, Kaina B.
    Clin Epigenetics; 2016 Sep 15; 8():49. PubMed ID: 27158275
    [Abstract] [Full Text] [Related]

  • 36. MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
    Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bähr O, Platten M, Tonn JC, Schlegel U, Marosi C, Goldbrunner R, Stupp R, Homicsko K, Pichler J, Nikkhah G, Meixensberger J, Vajkoczy P, Kollias S, Hüsing J, Reifenberger G, Wick W, DIRECTOR Study Group.
    Clin Cancer Res; 2015 May 01; 21(9):2057-64. PubMed ID: 25655102
    [Abstract] [Full Text] [Related]

  • 37. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S, Jordanov SH, Mitkova AV, Chalakov IJ, Melnicharov MB, Kunev KV, Mitev VI, Kaneva RP, Goranova TE.
    Head Neck; 2014 Aug 01; 36(8):1103-8. PubMed ID: 23804521
    [Abstract] [Full Text] [Related]

  • 38. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
    Jin J, Xie L, Xie CH, Zhou YF.
    Genet Mol Res; 2014 May 30; 13(2):4140-5. PubMed ID: 24938706
    [Abstract] [Full Text] [Related]

  • 39. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.
    Giannopoulou L, Chebouti I, Pavlakis K, Kasimir-Bauer S, Lianidou ES.
    Oncotarget; 2017 Mar 28; 8(13):21429-21443. PubMed ID: 28206954
    [Abstract] [Full Text] [Related]

  • 40. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    Kupcinskaite-Noreikiene R, Ugenskiene R, Noreika A, Rudzianskas V, Gedminaite J, Skieceviciene J, Juozaityte E.
    BMC Cancer; 2016 Jan 26; 16():40. PubMed ID: 26810771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.